Annals of Hematology

OCT 15, 2026 · JOURNAL ARTICLE

Evolving infectious epidemiology in acute myeloid leukemia in the contemporary era: a 13-year retrospective, single-center analysis of induction therapies

Annals of Hematology

Abstract We evaluated the 13-year (2012–2025) evolution of infectious epidemiology in a Polish acute myeloid leukemia (AML) induction cohort, contextualizing these findings within

OCT 8, 2026 · JOURNAL ARTICLE

Beyond disease control in chronic myeloid leukemia: Real-world quality of life across TKIs and treatment-free remission

Annals of Hematology

Abstract Tyrosine kinase inhibitors (TKIs) have transformed chronic myeloid leukemia (CML) into a chronic condition with near-normal life expectancy. As patients remain on therapy

SEP 28, 2026 · JOURNAL ARTICLE

Temporal trends and spatial patterns of leukemia subtypes in Asia, 1990–2021: a global burden of disease study

Annals of Hematology

Leukemia remains a critical public health challenge in Asia. We analyzed the epidemiology of five leukemia subtypes (Acute myeloid leukemia, AML; chronic myeloid leukemia, CML; acu

SEP 25, 2026 · JOURNAL ARTICLE

All-trans retinoic acid combined with thrombopoietin receptor agonists for refractory cancer therapy-induced thrombocytopenia: a retrospective single-center study

Annals of Hematology

Cancer therapy-induced thrombocytopenia (CTIT) is a common hematologic toxicity in patients with solid tumors. It often results in bleeding, delays or reductions in cancer treatmen

AUG 15, 2026 · JOURNAL ARTICLE

Beyond CAR-T: Multi-layered engineering strategies shaping the next generation of cellular cancer immunotherapy

Annals of Hematology

A narrative review proposing a conceptual framework for multi-platform cellular immunotherapy engineering, without reporting primary data, clinical trials, or comparative efficacy evidence.